CN1214799C - Medicine for treating sciatic nerve diseases - Google Patents
Medicine for treating sciatic nerve diseases Download PDFInfo
- Publication number
- CN1214799C CN1214799C CNB011064382A CN01106438A CN1214799C CN 1214799 C CN1214799 C CN 1214799C CN B011064382 A CNB011064382 A CN B011064382A CN 01106438 A CN01106438 A CN 01106438A CN 1214799 C CN1214799 C CN 1214799C
- Authority
- CN
- China
- Prior art keywords
- portions
- medicine
- treatment
- days
- sciatic nerve
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention discloses sciatic nerve medicine for treating sciatic nerve diseases, which is prepared from the following raw medicines: 0.2 to 0.7 portion of centipede, 0.3 to 1.5 portions of pangolin, 0.5 to 6 portions of safflower, 0.3 to 1.5 portions of stiff silkworm, 0.15 to 0.9 portion of scorpio, 0.4 to 9 portions of cassia twig, 0.7 to 8 portions of frankincense, 0.18 to 1.5 portions of bungarus minimus, 0.3 to 0.8 portion of nuxvomica, 0.5 to 6 portions of myrrh, 0.8 to 9 portions of atractylodes sinensis and 0.6 to 1.2 portions of szechwan lovage rhizome. The present invention has novel and unique formulation, rationality and obvious effect, one treatment course of medicine application has 15 days, the ordinary illness state can be recovered by using the medicine for 30 days, serious illness state can be recovered for four treatment courses (60 days), and the diseases do not relapse.
Description
The present invention relates to a kind of medicine, relate in particular to a kind of medicine of treatment sciatica of the specific effect of treatment to sciatica.
Sciatica is a clinical common diseases, and it is one-sided that sciatica mostly is, and it is acute or subacute that onset is.To thigh rear side and the radiated pain aggravation of the shank outside, night is obvious, aggravation when cough is exerted oneself by buttocks, hip.Health is slightly oblique to strong inclination when standing.Check: along sciatic nerve path buttocks point, rotor point, calf point and external malleolus point all can have tenderness and Lasegue to levy the positive.The light atrophy of Ipsilateral muscle, the shank outside and the hyperpathia of instep portion or go down, Achilles tendon reflex goes down or disappears, and Ipsilateral skin of leg temperature is low.Sciatica is sick to be sent out in each year order section, in case suffer from this disease, then pain gently then can not be lain up unbearably, heavy then can not fall asleep round the clock because of pain, causes great misery to patient and family members.At present, adopt following method to sciatica is general, 1, acute stage the rest of need lying in bed, hardboard bed preferably for sleeping in generally needs 3-4 week; 2, physical therapy, hot compress, infrared ray, shortwave are diathermanous etc. the neural swelling of elimination; 3, acupuncture and drug blockage; 4, Drug therapy; General doctor trained in Western medicine adopts Relafen, Lu Lifen, southern Shandong Bei Te, promise pine sheet or procaine block more; Though these medicines and method pain relieving are fast, alleviate patient's misery fast, its side effect is big, especially gastrointestinal tract is had very big stimulation, and main is that duration of efficacy is short, and the state of an illness can not get effective control, does not reach the purpose of radical cure; The effect of physical therapy, bed, sealing method is that pain relieving is fast, but recurs also fast.The traditional Chinese medical science then adopts QUANTIANMA JIAONANG, Giraldi daphne tablet, six China to stretch muscle capsule etc., and these Chinese patent medicines are characterized in that to effect a permanent cure, effect is lasting, and the patient benefits acceptance, the internal organs official is damaged less, is applicable to the treatment of chronic sciatica.But that its shortcoming is an effect is slow, the time long, general administration time 2-3 month.
The purpose of this invention is to provide a kind ofly has special treatment effect, its instant effect, cure rate height, sufferer to eradicate the medicine for the treatment of sciatica completely to sciatica.
Technical scheme of the present invention realizes in the following manner.
A kind of medicine for the treatment of sciatica, it is to make with following raw materials by weight proportions:
Scolopendra 0.2-0.7 part, Squama Manis 0.3-1.5 part, Flos Carthami 0.5-6 part, Bombyx Batryticatus 0.3-1.5 part, Scorpio 0.15-0.9 part, Ramulus Cinnamomi 0.4-9 part, Olibanum 0.7-8 part, Agkistrodon 0.18-1.5 part, Semen Strychni 0.3-0.8 part,
Not yetMedicine 0.5-6 part, Rhizoma Atractylodis 0.8-9 part, Rhizoma Chuanxiong 0.6-1.2 part.
The present invention can also make by following weight proportioning crude drug: Scolopendra 0.2-0.7 part, Squama Manis 0.3-1.5 part, Flos Carthami 0.5-6 part, Bombyx Batryticatus 0.3-1.5 part, Scorpio 0.15-0.9 part, Ramulus Cinnamomi 0.4-9 part, Olibanum 0.7-8 part, Agkistrodon 0.18-1.5 part, Semen Strychni 0.3-0.8 part,
Not yetMedicine 0.5-6 part, Rhizoma Atractylodis 0.8-9 part, Rhizoma Chuanxiong 0.6-1.2 part, Herba Ephedrae 0.8-7 part.
Preparation technology is: powder smalls Mel refining ball, glue capsule, powder all can altogether with the above-mentioned raw materials medicine.
Technical solution of the present invention is to think that according to theory of Chinese medical science sciatica is because of due to the wind-cold damp pathogen, wind being the primary exopathogen, changeable and benefaction, and take into account the medicine of expelling wind and removing dampness collateral dredging, so multiselect is with Rhizoma Atractylodis, Bombyx Batryticatus, Radix Saposhnikoviae, Agkistrodon, capable to reach the capable then blood of gas in order to the circulation of qi promoting of dispeling the wind in the compatibility, the blood sector-style is from the effect of going out, and adopts pain relieving class medicine such as Semen Strychni, Rhizoma Chuanxiong, Scorpio, Myrrha, Olibanum, Scolopendra to reach blood-activating and qi-promoting, removing obstruction in the collateral to relieve pain effect.
Good effect of the present invention is:
The prescription novelty is unique, rationally, instant effect, medication 15 days was a course of treatment, and the general state of an illness then medication can heal in 30 days entirely, and heavy then is promptly can heal entirely in 60 days four courses of treatment, and nothing has recurrence.
The invention will be further described below in conjunction with embodiment:
Embodiment one:
0.7 part of Scolopendra, 1.5 parts of Squama Maniss, 3 parts on Flos Carthami, 0.9 part of Bombyx Batryticatus, 0.9 part of Scorpio, 9 parts of Ramulus Cinnamomi, 8 parts of Olibanums, 1.5 parts of Agkistrodons, 0.8 part of Semen Strychni, 6 parts of Myrrhas, 9 parts of Rhizoma Atractylodis, 1.2 parts of Rhizoma Chuanxiongs, 5 parts in Herba Ephedrae.
Embodiment two:
0.4 part of Scolopendra, 1 part of Squama Manis, 6 parts on Flos Carthami, 0.9 part of Bombyx Batryticatus, 0.6 part of Scorpio, 4 parts of Ramulus Cinnamomi, 5 parts of Olibanums, 0.8 part of Agkistrodon, 0.6 part of Semen Strychni, 0.6 part of Myrrha, 5 parts of Rhizoma Atractylodis, 0.7 part of Rhizoma Chuanxiong, 2 parts in Herba Ephedrae.
Embodiment three:
0.7 part of Scolopendra, 1.5 parts of Squama Maniss, 3 parts on Flos Carthami, 1.5 parts of Bombyx Batryticatus, 0.9 part of Scorpio, 9 parts of Ramulus Cinnamomi, 8 parts of Olibanums, 1.5 parts of Agkistrodons, 08 part of Semen Strychni, 6 parts of Myrrhas, 9 parts of Rhizoma Atractylodis, 1.2 parts of Rhizoma Chuanxiongs, 1 part in Herba Ephedrae.
Implement four:
0.2 part of Scolopendra, 0.3 part of Squama Manis, 0.8 part in Herba Ephedrae, 0.5 part on Flos Carthami, 0.3 part of Bombyx Batryticatus, 0.15 part of Scorpio, 0.4 part of Ramulus Cinnamomi, 0.7 part of Olibanum, 0.18 part of Agkistrodon, 0.3 part of Semen Strychni, 0.5 part of Myrrha, 0.8 part of Rhizoma Atractylodis, 0.6 part of Rhizoma Chuanxiong, 0.8 part in Herba Ephedrae.
The result is as follows through the clinical practice effect experiment:
One, physical data:
Treat 139 routine sciatica patients and all come from hospital outpatient and ward patient, among the patient of treatment sciatica, the male is 127 people, and the women is 12 people, maximum 65 years old of year order, and minimum 15 years old, the course of disease is the longest 20 years, and was the shortest 1 year.
Two, experimental technique:
After the patient takes medicine for treating sciatic nerve diseases and should withdraw medicine of other relevant treatment sciatica in preceding 10 days, begin to take this medicine for treating sciatic nerve diseases made from embodiment 1, take a ball (every ball 3 grams are taken after mixing it with water with yellow wine before sleeping every night at every turn, 15 days is a course of treatment, and concrete grammar sees Table (one).
Table (one) experimental group and matched group grouping information slip
The group number | Number | The state of an illness and the course of disease | Remarks | |
One group | 67 people | The state of an illness is heavy, the course of disease is long | His method is invalid | |
Two groups | 72 people | The state of an illness is light, the course of disease is short | His method is invalid | |
One group | 12 3 people | The general state of an illness is strange, the course of disease is shorter | His method is alleviated |
Three, observation of curative effect:
(1) experimental group: oral medicine for treating sciatic nerve diseases, 15 days is a course of treatment, sleep every night before with yellow wine take after mixing it with water 3 the gram.The patient that the state of an illness is heavy, the course of disease is long takes medicine and heals entirely 3 courses of treatment, and 1 to 2 Cheng Quan of the general clothes of the patient that the state of an illness is light, the course of disease is short more.
(2), matched group: the patient obey simultaneously routine administration (as sodium salicylate, Relafen, promise pine sheet, procaine block etc.) do not have after 20-40 days complete, can only the partial symptoms respite, 98% pain again again after the drug withdrawal.
Medicine for treating sciatic nerve diseases treatment sciatica 139 routine efficacy analysis see Table 2
Experimental group 139 people | The course of treatment (15 days one courses of treatment) | Effective percentage (people %) | Cure rate (people %) | Remarks |
1-3 course of treatment | 139 people 100% | 132 people 96.4% | Followed the tracks of in 2 years to visit to examine and do not have recurrence | |
Matched group 123 people | 20-40 days | Remission | 2% | Drug withdrawal 98% is recurred again |
Above experimental result shows, the cure rate height of medicine for treating sciatic nerve diseases treatment sciatica, and effect is more definite.
Untoward reaction:
139 routine patients have slight dizziness, myasthenia of limbs reaction at period in a medicine after individual patient is taken medicine.
Four, conclusion:
Five, medicine for treating sciatic nerve diseases is aspect the treatment rheumatic sciatica, and curative effect is obvious, and total effective 100%, cure rate is 96.4%.Show in the observation that the age is little, course of disease weak point person curative effect is better.
Claims (2)
1, a kind of medicine for the treatment of sciatica, it is to make with following raw materials by weight proportions:
Scolopendra 0.2-0.7 part, Squama Manis 0.3-1.5 part, Flos Carthami 0.5-6 part, Bombyx Batryticatus 0.3-1.5 part, Scorpio 0.15-0.9 part, Ramulus Cinnamomi 0.4-9 part, Olibanum 0.7-8 part, Agkistrodon 0.18-1.5 part, Semen Strychni 0.3-0.8 part, Myrrha 0.5-6 part, Rhizoma Atractylodis 0.8-9 part, Rhizoma Chuanxiong 0.6-1.2 part.
2, a kind of medicine for the treatment of sciatica is characterized in that being made by following materials of weight proportions medicine:
Scolopendra 0.2-0.7 part, Squama Manis 0.3-1.5 part, Flos Carthami 0.5-6 part, Bombyx Batryticatus 0.3-1.5 part, Scorpio 0.15-0.9 part, Ramulus Cinnamomi 0.4-9 part, Olibanum 0.7-8 part, Agkistrodon 0.18-1.5 part, Semen Strychni 0.3-0.8 part, Myrrha 0.5-6 part, Rhizoma Atractylodis 0.8-9 part, Rhizoma Chuanxiong 0.6-1.2 part, Herba Ephedrae 0.8-7 part.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB011064382A CN1214799C (en) | 2001-01-18 | 2001-01-18 | Medicine for treating sciatic nerve diseases |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB011064382A CN1214799C (en) | 2001-01-18 | 2001-01-18 | Medicine for treating sciatic nerve diseases |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1313121A CN1313121A (en) | 2001-09-19 |
CN1214799C true CN1214799C (en) | 2005-08-17 |
Family
ID=4655451
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB011064382A Expired - Fee Related CN1214799C (en) | 2001-01-18 | 2001-01-18 | Medicine for treating sciatic nerve diseases |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1214799C (en) |
-
2001
- 2001-01-18 CN CNB011064382A patent/CN1214799C/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN1313121A (en) | 2001-09-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101972453B (en) | Chinese medicinal liquor for treating rheumatic and rheumatoid arthritis and preparation method thereof | |
CN103463381B (en) | Traditional Chinese medicine preparation for treating rheumatism bone pain and preparation method thereof | |
CN1390585A (en) | Chinese medicine for detoxication purpose and its preparing process | |
CN100536886C (en) | External-applied traditional Chinese medicine composition for treating gout | |
CN1069527C (en) | Medicine for hyperosteogeny and wind-cold syndrome | |
CN101732501A (en) | Chinese medicament for treating psoriasis | |
CN101530516B (en) | Chinese medicament for treating appendicitis | |
CN1214799C (en) | Medicine for treating sciatic nerve diseases | |
CN101181427B (en) | Externally used medicament for curing scaly tetter | |
CN1181878C (en) | Detumescence plaster | |
CN106389550A (en) | Traditional Chinese medicine for treating herpes zoster | |
CN100566741C (en) | A kind of antipsoriatics thing | |
CN104274785A (en) | Traditional Chinese medicine preparation for hand tendon injuries and preparation method thereof | |
CN103393799B (en) | A kind of Chinese medicine composition for the treatment of acquired immune deficiency syndrome (AIDS) and preparation method thereof | |
CN1305510C (en) | Medicine for treating intractable fever | |
CN106421502A (en) | Pharmaceutical composition for treating infant jaundice | |
CN101361828B (en) | Medicine for treating scapulohumeral periarthritis and preparation method thereof | |
CN101057915A (en) | Capsule for nourishing kidney and treating rheumatalgia | |
CN1404850A (en) | Anti-inflammatory pain-releaving and swelling-diminishing external-use medicine | |
CN1283282C (en) | Chinese traditional medicine for treating appendicitis | |
CN1065137C (en) | Liniment made of traditional Chinese medicine for treating pharyngitis, and prepn. method therefor | |
CN1245195C (en) | Traditional Chinese medicine composition for treating SARS and preparation process thereof | |
CN1209156C (en) | Medicinal wine for curing old injury recurrent pain | |
CN1092976C (en) | Application of endive in preparing medicine for treating tuberculosis | |
CN103070998B (en) | Externally-applied plaster for curing pain of rheumatic joints |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20050817 Termination date: 20100219 |